|
| |
| | | 38133 | | 06.07.1977 | | Opella Healthcare Switzerland AG | | 21.12.2007 | | | | | | | | | | | 01.01.10. | | | | 01.01.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Aspégic 100 | Pulver in Beutel | Soluble Powder (DL-Lysine Acetylsalicylate 180 mg) | N02BA01 | CI | | 02 | Aspégic Mite | Pulver in Beutel | Soluble Powder (DL-Lysine Acetylsalicylate 450 mg) | N02BA01 | CI | | 03 | Aspégic 500 | Pulver in Beutel | Soluble Powder (DL-Lysine Acetylsalicylate 900 mg) | N02BA01 | CI | | 04 | Aspégic Forte | Pulver in Beutel | Soluble Powder (DL-Lysine Acetylsalicylate 1.8 g) | N02BA01 | CI |
|
|
|
